T cell activation modulates retrovirus-mediated gene expression

Area of Science:

• Immunology
• Gene Therapy
• Molecular Biology

Background:

• Efficient gene delivery and expression in primary human T cells are critical for T lymphocyte-based gene therapy.
• Retrovirus-mediated gene transfer is a common method for introducing genetic material into T cells.

Purpose of the Study:

• To evaluate retrovirus-mediated gene transfer and proviral gene expression in human T cells activated by different methods.
• To investigate the impact of T cell activation signaling on the regulation of proviral gene expression.

Main Methods:

• Human T cells were activated using immobilized anti-CD3 monoclonal antibody (MAb) plus interleukin 2, or cis costimulation with anti-CD3/anti-CD28 MAbs on beads.
• A modified human interleukin 1beta (IL-1beta) cDNA was inserted into the MFG retroviral vector as an indicator gene.
• Retroviral transduction frequencies and proviral gene expression (RNA and protein levels) were analyzed.

Main Results:

• Retroviral transduction frequencies were similar between the two activation methods.
• T cells activated with anti-CD3/anti-CD28 beads showed greater early proviral gene expression, correlating with enhanced cytokine responses and proliferation.
• Proviral gene expression decreased in later cultures without T cell signaling but was reinduced upon restimulation.

Conclusions:

• T cell activation status significantly influences retroviral gene expression in human T cells.
• Absence of T cell signaling downmodulates proviral gene expression, a key consideration for clinical gene therapy strategies.
• Optimized T cell activation protocols may improve the efficacy of retrovirus-mediated gene therapy.